Table 2Evidence examining the relationship between shorter versus longer durations of any human milk feeding and allergic rhinitis1

Author and year

Study design (study/cohort name when applicable)

Country

Notable sample characteristicsShorter versus longer duration of any human milk feeding exposure2Significant associations with allergic rhinitisNonsignificant associations with allergic rhinitis
Evidence from birth to 24 months

Kull 2002 (4)

Prospective cohort (BAMSE)

Sweden

N=3,791

Baseline: Birth

Race/ethnicity NR

Partial BF ≥6 mo vs <6 moNoneSuspected allergic rhinitis by 2 y: OR 0.80 (95% CI: 0.58, 1.09)
Evidence in childhood

Codispoti 2010 (6)

Prospective cohort (CCAAPS)

US

N=80 African Americans, 218 non-African Americans

Baseline: Birth

Race/ethnicity: 22.2% African American, 77.8% non-African American

Risk: 100% family history (≥1 parent)

BF duration (mo)Allergic rhinitis at age 3 y in African American subsample: OR 0.8 (95% CI: 0.6, 0.9)Allergic rhinitis at age 3 y in the non-African American subsample: OR 1.0 (95% CI: 0.96, 1.1)

Kramer 2007 (5)

Cluster RCT3 (PROBIT)

Belarus

N=13,889

Baseline: Birth

Race/ethnicity NR

Experimental group (higher rates of any BF measured at 3, 6, 9, and 12 mo) vs control groupNone

Ever had hay fever symptoms by 6.5 y: OR 1.1 (95% CI: 0.6, 1.9)

Hay fever symptoms in the past 12 mo at 6.5 y: OR 1.0 (95% CI: 0.6, 1.8)

Larsson 2008 (7)

Prospective cohort (DBH)

Sweden

N=4,779

Baseline: 1-4 y

Race/ethnicity NR

BF duration <3 mo vs >6 moNone

5 year cumulative incidence of rhinitis by age 6-9 y: OR 0.96 (95% CI: 0.63, 1.46)

5 year cumulative incidence of any rhinitis symptoms by age 6-9 y: OR 0.80 (95% CI: 0.59, 1.07)

BF duration 3-6 mo vs >6 moNone

5 year cumulative incidence of rhinitis during by age 6-9 y: OR 0.94 (95% CI: 0.69, 1.29)

5 year cumulative incidence of any rhinitis symptoms during by age 6-9 y: OR 1.03 (95% CI: 0.84, 1.25)

Nwaru 2013 (9)

Prospective cohort (DIPP)

Finland

N=3,112

Baseline: Birth

Race/ethnicity NR

Risk: 100% high-risk genotype for T1D

Total BF <5 mo vs >9.5 moNoneAllergic rhinitis at 5 y: OR ~1.3 (95% CI: ~1.0, ~1.8)
Total BF 5-9.5 mo vs >9.5 moNoneAllergic rhinitis at 5 y: OR ~1.2 (95% CI: ~0.9, ~1.5)

Sandini 2011 (10)

Prospective cohort4

Finland

N=891

Baseline: Birth

Race/ethnicity NR

Risk: 100% family history (≥1 parent)

BF duration ≥2 mo vs <2 moNoneAllergic rhinitis at 5 y: OR 1.87 (95% CI: 0.55, 6.36)

von Kobyletzki 2012 (8)

Prospective cohort (DBH)

Sweden

N=3,124

Baseline: 1-2 y

Race/ethnicity NR

BF ≤6 mo vs >6 moNone5 y cumulative incidence of rhinitis by age 6-7 y: OR 1.02 (95%CI: 0.73, 1.43)
1

Abbreviations: BAMSE - Swedish abbreviation for children, allergy, milieu, Stockholm, epidemiology, BF - breastfeeding/breastfed, CCAAPS - Cincinnati Childhood Allergy and Air Pollution Study, CI - confidence interval, DBH - Dampness in Buildings and Health, DIPP - Type 1 Diabetes Prediction and Prevention, mo - months, NR - not reported, OR - odds ratio, PROBIT - Promotion of Breastfeeding Intervention Trial, RCT - randomized controlled trial, T1D - type 1 diabetes, y - years

2

Exposures, as defined by the authors of the studies included in the body of evidence, which address shorter versus longer durations of any human milk feeding or vice versa

3

Cluster RCT of an intervention to promote prolonged duration and exclusivity of breastfeeding rather than an RCT of breastfeeding per se

4

The cohort was sampled from an RCT however the data of interest for this SR are unrelated to randomization

From: WHAT IS THE RELATIONSHIP BETWEEN SHORTER VERSUS LONGER DURATIONS OF ANY HUMAN MILK FEEDING AND FOOD ALLERGIES, ALLERGIC RHINITIS, ATOPIC DERMATITIS, AND ASTHMA?

Cover of Shorter Versus Longer Durations of Any Human Milk Feeding and Food Allergies, Allergic Rhinitis, Atopic Dermatitis, and Asthma: A Systematic Review
Shorter Versus Longer Durations of Any Human Milk Feeding and Food Allergies, Allergic Rhinitis, Atopic Dermatitis, and Asthma: A Systematic Review [Internet].
Güngör D, Nadaud P, Dreibelbis C, et al.
Alexandria (VA): USDA Nutrition Evidence Systematic Review; 2019 Apr.
Copyright Notice

The contents of this document may be used and reprinted without permission. Endorsements by NESR, NGAD, CNPP, FNS, or USDA of derivative products developed from this work may not be stated or implied.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.